Northwest Biotherapeutics, Inc  

(Public, NASDAQ:NWBO)   Watch this stock  
-0.10 (-4.72%)
Feb 5 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.01 - 2.20
52 week 1.85 - 12.55
Open 2.12
Vol / Avg. 225,115.00/541,769.00
Mkt cap 203.22M
P/E     -
Div/yield     -
EPS -1.94
Shares 95.86M
Beta 2.36
Inst. own 44%

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 7771.48% -9328.34%
Operating margin -4540.55% -6925.31%
EBITD margin - -6955.43%
Return on average assets 156.55% -360.54%
Return on average equity - -
Employees 12 -
CDP Score - -


4800 Montgomery Ln Ste 800
BETHESDA, MD 20814-3676
United States - Map
+1-240-4979024 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Northwest Biotherapeutics, Inc. is a biotechnology company. The Company is focused on developing immunotherapy products to treat cancer. The Company's platform technology, DCVax, uses activated dendritic cells to mobilize a patient's own immune system, including T cells, B cells and antibodies and natural killer cells, among others to attack cancer cells. DCVax is designed to target a set of biomarkers on the patient's tumor. DCVax product lines are made from the patient's own dendritic cells, which are freshly isolated, and matured and activated. The Company's DCVax product lines include DCVax-L, DCVax-Direct and DCVax-Prostate. DCVax-L is made with cancer antigens from tumor lysate. DCVax-Direct incorporates a set of tumor antigens in situ. DCVax-Prostate product line is developed based on the antigen, PSMA (Prostate Specific Membrane Antigen), which is found on all late stage prostate cancers.

Officers and directors

Linda F. Powers Chairperson of the Board, President, Chief Executive Officer
Age: 59
Bio & Compensation  - Reuters
Leslie J. Goldman Senior Vice President - Business Development
Age: 70
Bio & Compensation  - Reuters
Anthony E. Maida Ph.D. Senior Vice President - Clinical Research
Age: 61
Bio & Compensation  - Reuters
Marnix L. Bosch Ph.D Chief Technical Officer
Age: 55
Bio & Compensation  - Reuters
Alton L. Boynton Ph.D. Chief Scientific Officer, Director
Age: 71
Bio & Compensation  - Reuters
Susan B. Bayh Independent Director
Age: 55
Bio & Compensation  - Reuters
Cofer Black Independent Director
Bio & Compensation  - Reuters
Robert A. Farmer Independent Director
Age: 75
Bio & Compensation  - Reuters
Jerry J. Jasinowski Independent Director
Age: 72
Bio & Compensation  - Reuters
Navid Malik Independent Director
Age: 46
Bio & Compensation  - Reuters